Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
about
Targeting heat shock proteins to modulate α-synuclein toxicitySwitching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective.DOPA-sparing strategy in the treatment of young onset Parkinson's diseasePreparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson's disease and its evolution study.Placement of the AbbVie PEG-J tube for the treatment of Parkinson's disease in the interventional radiology suite.Preparation of rotigotine-loaded microspheres and their combination use with L-DOPA to modify dyskinesias in 6-OHDA-lesioned rats.
P2860
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
@en
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.
@nl
type
label
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
@en
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.
@nl
prefLabel
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
@en
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease.
@nl
P2860
P356
P1476
Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease
@en
P2093
Carol Lane
O K Sujith
P2860
P304
P356
10.1177/1756285608101378
P577
2009-03-01T00:00:00Z